Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2021 Jul 28;18(7):e1003711. doi: 10.1371/journal.pmed.1003711

Impact of assessment and intervention by a health and social care professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults: A randomised controlled trial

Marica Cassarino 1,2, Katie Robinson 1, Dominic Trépel 3, Íde O’Shaughnessy 4, Eimear Smalle 4, Stephen White 4, Collette Devlin 1, Rosie Quinn 5, Fiona Boland 6, Marie E Ward 7, Rosa McNamara 8, Fiona Steed 9, Margaret O’Connor 10,11, Andrew O’Regan 11, Gerard McCarthy 12, Damien Ryan 13, Rose Galvin 1,*
Editor: Stephanie A Eucker14
PMCID: PMC8318294  PMID: 34319971

Abstract

Background

Older adults frequently attend the emergency department (ED) and experience high rates of adverse events following ED presentation. This randomised controlled trial evaluated the impact of early assessment and intervention by a dedicated team of health and social care professionals (HSCPs) in the ED on the quality, safety, and clinical effectiveness of care of older adults in the ED.

Methods and findings

This single-site randomised controlled trial included a sample of 353 patients aged ≥65 years (mean age = 79.6, SD = 7.01; 59.2% female) who presented with lower urgency complaints to the ED a university hospital in the Mid-West region of Ireland, during HSCP operational hours. The intervention consisted of early assessment and intervention carried out by a HSCP team comprising a senior medical social worker, senior occupational therapist, and senior physiotherapist. The primary outcome was ED length of stay. Secondary outcomes included rates of hospital admissions from the ED; hospital length of stay for admitted patients; patient satisfaction with index visit; ED revisits, mortality, nursing home admission, and unscheduled hospital admission at 30-day and 6-month follow-up; and patient functional status and quality of life (at index visit and follow-up). Demographic information included the patient’s gender, age, marital status, residential status, mode of arrival to the ED, source of referral, index complaint, triage category, falls, and hospitalisation history. Participants in the intervention group (n = 176) experienced a significantly shorter ED stay than the control group (n = 177) (6.4 versus 12.1 median hours, p < 0.001). Other significant differences (intervention versus control) included lower rates of hospital admissions from the ED (19.3% versus 55.9%, p < 0.001), higher levels of satisfaction with the ED visit (p = 0.008), better function at 30-day (p = 0.01) and 6-month follow-up (p = 0.03), better mobility (p = 0.02 at 30 days), and better self-care (p = 0.03 at 30 days; p = 0.009 at 6 months). No differences at follow-up were observed in terms of ED re-presentation or hospital admission. Study limitations include the inability to blind patients or ED staff to allocation due to the nature of the intervention, and a focus on early assessment and intervention in the ED rather than care integration following discharge.

Conclusions

Early assessment and intervention by a dedicated ED-based HSCP team reduced ED length of stay and the risk of hospital admissions among older adults, as well as improving patient satisfaction. Our findings support the effectiveness of an interdisciplinary model of care for key ED outcomes.

Trial registration

ClinicalTrials.gov NCT03739515; registered on 12 November 2018.


Marica Cassarino and colleagues evaluate an intervention for early assessment of older patients in emergency care.

Author summary

Why was the study done?

  • Some studies suggest that older patients presenting to the emergency department (ED) could benefit from receiving early assessment and intervention by a dedicated health and social care professional (HSCP) team, particularly in terms of safer discharges and increased patient and staff satisfaction.

  • To date, no methodologically robust studies exist that have tested the effectiveness of this interdisciplinary model of ED care for older adults.

  • In this randomised controlled trial, we evaluated the impact of an ED-based HSCP team dedicated to older patients on ED length of stay, incidence of hospital admissions, and other measures of quality and safety of care.

What did the researchers do and find?

  • Compared to those receiving usual ED care, patients who were treated by the HSCP team spent less time in the ED, had lower rates of hospital admission, and were satisfied with their care, as well as reporting better function at follow-up.

  • We observed no differences in the numbers of patients re-presenting to the ED at 30 days or 6 months.

What do these findings mean?

  • Having a dedicated HSCP team that provide early assessment and intervention to older people with lower urgency conditions can improve quality and timeliness of ED care.

  • Further research is needed to understand whether these benefits can extend to other patient populations, as well as clarifying implications for integration of care post-discharge from the ED.

Introduction

Internationally, emergency departments (EDs) face significant challenges in delivering high-quality and timely patient care set against a background of increasing patient numbers and limited hospital resources [1,2]. A growing ageing population and a higher number of individuals with multimorbidity are among the main demographic drivers of increases in ED attendances [3,4], which, in turn, lead to ED crowding. Research has demonstrated that ED crowding contributes to a reduction in the quality of patient care, delays in commencement of treatment, increased mortality, poorer adherence to recognised clinical guidelines, and ultimately poorer health outcomes [4,5].

The implementation of quality improvement strategies that can help to streamline patient flow in the ED has been shown to enhance quality of care [6]; these strategies are especially important for older adults, whose health outcomes are negatively impacted by frequent ED attendances [7,8] and ED crowding. Increasingly, evidence from international studies has supported the introduction of teams of health and social care professionals (HSCPs) to the ED to provide specialised interdisciplinary care, which can contribute to more timely and safer decision-making [915]. A recent systematic review [16] indicated that care coordination teams of HSCPs (including physiotherapists, occupational therapists, and medical social workers), which provide early assessment and intervention to older adults in the ED can lead to safer discharges and increase patient and staff satisfaction; however, the quality of the evidence is mixed, primarily due to weaknesses in study designs and heterogeneity of patient groups and outcomes of interest. On the other hand, ED stakeholders have reported positive perceptions of HSCPs working in the ED, in particular the added value of having HSCPs with specialised skills working in an interdisciplinary manner to provide timely care to older adults, while at the same time reducing the workload of the ED medical staff [17,18]. This evidence suggests that ED-based HSCP teams could be a viable and effective solution to improve the flow and outcomes of ED patients, particularly those who might benefit the most from interdisciplinary holistic assessment [19]. However, no robust investigations of the effectiveness of this model of care have been carried out to date [16].

Building on the Medical Research Council (MRC) framework for the development and evaluation of complex interventions [20], this randomised controlled trial [21] aimed to evaluate the impact of a dedicated team of HSCPs in the ED on the quality, safety clinical, and cost-effectiveness of care of older adults in the ED. Specifically, this study describes the findings on the clinical effectiveness of the intervention in terms of key ED and patient outcomes. An analysis of cost-effectiveness of the intervention is presented separately [22].

Methods/design

Design and setting

The study represents a single-centre parallel group randomised controlled trial, which investigates the clinical effectiveness of early assessment and intervention by a dedicated HSCP team on older adults in the ED of a university teaching hospital with a large catchment area in the Mid-West of the Republic of Ireland. The university teaching hospital sits within a larger hospital group with 6 hospital sites but all function as a single hospital system caring for a substantially rural population of approximately 385,000. The university teaching hospital is the only hospital in the group that has a full 24/7/365 emergency care and critical care service and has 455 inpatient beds.

This report adheres to the Consolidated Standards of Reporting Trials (CONSORT) guidelines [23]; the CONSORT Checklist is included in the S1 CONSORT Checklist and the Participant Flowchart is presented in Fig 1. The trial protocol is registered on ClinicalTrials.gov (NCT03739515) and is published elsewhere [21].

Fig 1. Participant flow chart, based on the CONSORT 2010 diagram (23).

Fig 1

ED, emergency department; HSCP, health and social care professionals; QoL, quality of life.

The study received ethics approval from the Health Service Executive (HSE) Mid-Western Regional Hospital Research Ethics Committee (Ref: 103/18).

Participants and recruitment

Patients were eligible for participation in the study if they were aged ≥65 years, medically stable, able to provide written consent, and presented to the ED during HSCP operational hours with one of the index complaints included in Table 1. Eligible patients were identified by the dedicated HSCP team employed in the project through the ED triage system and via consultation with the ED medical staff. Prospective patients who had a Manchester Triage System score (MTS) of 3 to 5 (respectively, urgent, standard, or nonurgent) and who were categorised at triage with limb problems, falls, unwell adult, back pain, urinary problems, or ear/facial problems were invited to take part. The HSCP team completed baseline measurement and randomisation prior to assessment by a doctor in emergency medicine (EM). Patients who presented with an MTS score of 2 (very urgent) or any of the MTS categories not listed above were invited to take part following consultation with the EM doctor and completion of diagnostic work-up, to determine suitability and indication for HSCP assessment, e.g., MTS score 2 presenting with falls, life-threatening condition/injury out-ruled and medically stable. All potential participants were provided with an information sheet, briefed on the study, and given time to decide or consult with a caregiver (if present). Patients who were willing to take part were then asked to read and sign a written informed consent form. Consent procedures and mechanisms relating to data controlling and processing complied with the EU General Data Protection Regulation 2016/679 and with the Data Protection Act 2018 [(Section 36(2)) (Health Research) Regulations 2018]. The study received ethical approval from the HSE Mid-Western Regional Hospital Research Ethics Committee (Ref: 103/18).

Table 1. Patient eligibility criteria.

Inclusion criteria Exclusion criteria
Aged ≥65 years Aged under 65 years
MTS 3–5 MTS 1–2*
Off baseline mobility and functional status Neither the patient nor the carer can communicate in English sufficiently to complete informed consent or baseline assessment
Capacity and willingness to provide informed consent Lacking capacity to provide informed consent**
Presenting during HSCP operational hours (8 AM–5 PM Monday–Friday) Presenting outside HSCP operational hours (5 PM–8 AM or on Saturday/Sunday)
Presenting with any of the following complaints, as per MTS [24]:
Before medical work-up:
    Limb problems
    Falls
    Unwell adult
    Back pain
    Urinary problems
    Ear and facial problems
Presenting with complaints other than described in the inclusion list.

EM, emergency medicine; HSCP, health and social care professional; MTS, Manchester Triage System.

*MTS score 1–2 only recruited after EM diagnostic work-up and suitability for HSCP assessment determined.

**In cases where there was a clinical concern regarding capacity to consent, the 4AT tool was used to screen for cognitive impairment and in participants where there was evidence of moderate-profound impairment, the patient’s nominated contact person was contacted for consent.

Baseline data collection

After consenting to take part, each participant underwent a baseline assessment with a member of the HSCP team; this had an approximate duration of 30 minutes. Demographic information included the patient’s gender, age, marital status (single, married, widowed, separated), residential status (living alone versus living with others), mode of arrival to the ED (private transport, ambulance, public transport, other), source of referral (self-referral, general practitioner, injury unit, walk-in clinic, other), index complaint (as per Table 1), and triage category. The health assessment comprised of the following measurements: functional status measured through the Barthel index for activities of daily living (ADLs) [25]; health-related quality of life through the EuroQoL survey 5-dimension and 5-levels form (EQ-5D-5L) [26]; risk of adverse outcomes measured via the Identification of Seniors At Risk (ISAR) screening tool [27]; frailty via the Rockwood’s Clinical Frailty Scale [28]; nutritional status through the Mini Nutritional Assessment (MNA) short form [29]; whether the person had experienced any falls in the 3 months prior to the ED visit; whether the person had been hospitalised in the 6 months prior to the ED visit. Functional status and quality of life were also assessed at follow-up.

Randomisation

Computer-generated random numbers in blocks of 20 were created by a researcher independent of the recruitment process (MC) using an internet-based system (https://www.randomizer.org/) and placed in sealed opaque envelopes. These numbers were securely stored in the presealed envelopes in a locked drawer in the research facility on the hospital site. Allocation was revealed by a research nurse (CD) after recruitment of eligible participants and the conduct of the baseline assessment by accessing and opening the next envelope in the sequence and providing the randomisation information to the research team and patient simultaneously. After allocation was revealed, participants were assigned to either the experimental group (HSCP intervention) or the control group (routine care). Due to the nature of the study, blinding of participants and personnel was not possible after allocation to intervention or control.

Experimental and control interventions

Intervention

Participants in the intervention group were assessed by one or more members of the dedicated HSCP team (one senior physiotherapist, one senior occupational therapist, and one senior medical social worker). The assessment included, but was not be limited to, an interdisciplinary assessment of functional and mobility status, cognition, and psychosocial needs. Members of the HSCP team were guided by their clinical expertise, scope, and codes of professional practice. Details of the common domains covered by the HSCP team in their assessment and intervention are presented in S1 Intervention Characteristics. Interventions prescribed by the HSCP team were based on subjective and objective assessment of patients and included prescription of mobility aids and enabling ADL equipment, provision of home exercise programmes, education of self-management strategies, and onward referral to alternative care pathways, as deemed appropriate. All assessments and interventions were included in the ED chart of individual participants. The HSCP team worked together with the ED medical and ED nursing team to develop an optimal recommendation for the patient in terms of discharge and relevant interventions. The HSCP team had a dedicated cubicle in the ED where they performed assessment and intervention, as appropriate. However, a number of assessments were completed trolley side after individual risk assessment.

Control group

The comparison group received routine care provided by the ED medical and nursing staff for the duration of their stay in the ED. Prior to this study, there was no dedicated team of HSCPs to assess and intervene with older adults who presented to the ED at this hospital. Ad hoc services were provided by HSCPs if they were requested by a member of the team in the ED. This process continued for the duration of the trial, but services to the control group were provided by HSCPs that were not part of the dedicated HSCP team in the ED.

Outcomes

The primary outcome of the study was the duration of stay in the ED in hours from the time of arrival in the ED to the time of discharge. Secondary outcomes included the rate of hospital admission from the ED, hospital length of stay for admitted patients, and patient satisfaction with the ED index visit assessed through the 18-item Patient Satisfaction Questionnaire (PSQ-18) [30] at the time of the visit. Follow-up outcomes included the number of unplanned ED reattendances, unscheduled hospital visits, and nursing home admission within 30 days and 6 months of the initial index visit. Functional status [25] and quality of life [26] were also assessed at follow-up (30 days and 6 months).

Data collection

The research nurse collected data on objective measures (e.g., ED length of stay, admission rates, ED revisits, unscheduled hospital admissions) using the hospital routine databases. A hospital attendance or admission at any of the 3 other local hospitals in this hospital group would also be captured on this database. Patient-reported outcomes were assessed via questionnaires either in person (at the time of the ED index visit) or via a telephone call at follow-up: These included patient satisfaction (index visit), functional status, mortality, and quality of life (30 days and 6 months). Each participant in the study was assigned a unique numerical code in order to link data collected at baseline to the follow-up. Data on healthcare utilisation were also collected at 30 days and 6 months and will be included in a separate cost-effectiveness publication (in preparation at the time of submission). No reminder of indications provided at discharge was given during the follow-up phone calls.

Data analysis

Statistical analyses were conducted using Stata 12 MP (StataCorp LP, Texas). Prespecified analyses can be found in the trial protocol [21]. Participants’ characteristics at baseline and follow-up stratified by intervention and control group are described using means and standard deviation for continuous measures (e.g., patient’s age, quality of life subdomains); median and interquartile ranges for continuous measures, which showed evidence of skewness (e.g., ED length of stay); and frequencies and percentages for categorical measures (e.g., hospital admissions, ED revisits at follow-up).

Differences between the 2 groups in terms of ED length of stay and hospital length of stay were analysed using the Wilcoxon–Mann–Whitney test. Logistic regression was used to explore differences between the intervention and control in hospital admissions at the index visit, as well as 30-day and 6-month ED revisits, unscheduled hospital, and nursing home admissions. The models were adjusted for patient’s age and ISAR score at baseline and results were presented as odds ratios (ORs) and 95% confidence intervals (CIs). Patients’ function and each of the quality of life subdomains at follow-up were explored using an analysis of covariance (ANCOVA) fitting a linear regression model adjusting for patient’s age, ISAR score, baseline Barthel ADL index (for function), and baseline quality of life (for quality of life). The differences in patient satisfaction scores with their index visit were analysed using an independent samples t test with 95% CI.

Sample size

The sample size was calculated based on our primary outcome (ED length of stay) using G*Power version 3.1. Drawing on the data from the Patient Experience Time (PET) database employed in the hospital ED, the average ED length of stay for patients aged 65 and older for the period 2016 to 2017 was 13.95 hours (standard deviation = 12.49 hours) [21]. Estimating a 40% decrease in ED length of stay in the intervention group (mean = 8.37 hours), as observed in previous studies [15], and with a 20% attrition rate to follow-up, a sample size of 258 patients (129 in each group) was required to achieve 90% power with two-tailed tests at an alpha level of 0.05.

Patient and public involvement

The research questions and outcome measures for this trial were informed by a participatory study where inputs from multiple stakeholders, including ED patients and caregivers, were gathered with regard to this model of care [18]; patients’ insights were also useful to guide decisions on the dissemination of the findings of this intervention. Patients were involved in this trial as study participants at the time of data collection; given the nature of the study and the setting of data collection, it was felt that involving patients as coinvestigators may cause a burden for individuals who may already present vulnerabilities. Nonetheless, patients’ feedback on the intervention was gathered as part of the satisfaction questionnaire.

Results

Participants were recruited from December 2018 until the end of May 2019. As shown in the trial flow in Fig 1, a total of 392 patients were initially identified as eligible and 353 were enrolled in the trial: 176 in the intervention group (HSCP team) and 177 in the control group (usual ED care). Of the 39 patients not recruited, 38 refused to take part because they were not interested (65%) or did not feel well enough to participate (reasons cited included pain, tiredness, or distress) (35%); one patient was excluded presented as a return rather than a new visit.

At the index visit, data relating to ED length of stay and hospital admissions was collected for all 353 patients. A total of 35 patients (13 in the control and 21 in the intervention group) did not complete the satisfaction questionnaire.

At 30-day follow up, data on objective outcomes (ED revisits, unscheduled hospital admissions, and nursing home admissions) were available for all participants; data on function were available for 323 patients (n = 30 lost to follow-up because dead or refused/unreachable); and data on quality of life subdomains were available for 329 patients (n = 24 lost to follow-up). At 6 months, analyses for ED revisits and unscheduled hospital admissions included 346 patients (excluding 7 participants who had died within 30 days); analyses for nursing home admissions included 304 patients (excluding 7 participants who had died within 30 days and 42 already admitted to nursing homes within 30 days). In terms of patient-reported outcomes, data for function were available for 291 patients (n = 62 lost to follow-up because dead or refused/unreachable), and data for quality of life across all subdomains were present for 297 patients (n = 56 lost to follow-up).

Table 2 presents the participants’ baseline characteristics by group and for the overall sample, including both demographic and health measures. The sample mean age was 79.6 years (SD = 7.01 years), with 59.2% female participants. Patients included in the trial presented an MTS score ranging from 2 “very urgent” to 4 “standard,” while no patients with a score of 1 (immediate) or 5 (nonurgent) were part of the sample. In terms of baseline differences between the 2 groups (see Table 2), we observed that patients in the control group were slightly older than those in the intervention group and more likely to be in triage category 3, whereas participants in the intervention group reported more pain or discomfort than those in the control group.

Table 2. Baseline characteristics.

Characteristic Control (n = 177) Intervention (n = 176) Overall (N = 353)
Female, n (%) 101 (57.1) 108 (61.4) 209 (59.2)
Age, mean ± SD 80.6 ± 6.82 78.6 ± 7.08 79.6 ± 7.01
Marital status, n (%)
    Single 28 (15.8) 23 (13.1) 51 (14.5)
    Married 65 (36.7) 70 (39.8) 135 (38.2)
    Divorced 6 (3.4) 5 (2.8) 11 (3.1)
    Widowed 78 (44.1) 75 (42.6) 153 (43.3)
    Unknown 0 3 (1.7) 3 (0.9)
Residential status, n (%)
    Lives alone 79 (44.6) 74 (42.1) 153 (43.3)
    Lives with family 95 (53.7) 88 (50.0) 183 (51.8)
    Nursing home resident 1 (0.6) 6 (3.4) 7 (2.0)
    Other* 2 (1.1) 8 (4.6) 10 (2.8)
Mode of entry, n (%)
    Ambulance 86 (48.6) 85 (48.3) 171 (48.4)
    Private transport 88 (49.7) 89 (50.6) 177 (50.1)
    Public transport 2 (1.1) 2 (1.1) 4 (1.1)
    Walk-in 1 (0.6) 0 1 (0.3)
Referral, n (%)
    GP services 71 (40.1) 58 (33.0) 129 (36.5)
    Self-referral 102 (57.6) 115 (65.3) 217 (61.5)
    Nursing home 3 (1.7) 1 (0.6) 4 (1.1)
    Walk-in clinic 1 (0.6) 1 (0.6) 2 (0.6)
    Other** 0 1 (0.6) 1 (0.3)
Index complaint, n (%)***
    Limb problems 61 (34.5) 73 (41.5) 134 (38.0)
    Unwell adult 39 (22.0) 24 (13.6) 63 (17.9)
    Falls 28 (15.8) 26 (14.8) 54 (15.3)
    Back pain 15 (8.5) 22 (12.5) 37 (10.5)
    Other 34 (19.2) 31 (17.6) 65 (18.4)
Triage category, n (%)
    2 11 (6.2) 25 (14.2) 36 (10.2)
    3 155 (87.6) 140 (79.6) 295 (83.6)
    4 11 (6.2) 11 (6.3) 22 (6.2)
Falls in the past 3 months, n (%) 92 (52.3) 96 (54.6) 188 (53.4)
Hospitalised in the past 6 months, n (%) 63 (35.59) 50 (28.57) 113 (32.10)
Barthel index, mean ± SD 16.3 ± 3.68 16.8 ± 3.13 16.6 ± 3.43
EQ-5D-5L, mean ± SD
    Mobility (n = 353) 2.86 ± 1.35 2.64 ± 1.29 2.75 ± 1.32
    Self-care (n = 353) 2.54 ± 1.34 2.38 ± 1.33 2.45 ± 1.34
    Usual activities (n = 353) 2.99 ± 1.27 2.80 ± 1.26 2.91 ± 1.27
    Pain/discomfort (n = 353) 2.57 ± 1.17 2.84 ± 1.16 2.70 ± 1.17
    Anxiety/depression (n = 351) 1.60 ± 0.89 1.53 ± 0.84 1.57 ± 0.86
ISAR score, n (%)
    <2 34 (19.2) 41 (23.3) 75 (21.3)
    ≥2 143 (80.8) 135 (76.7) 278 (78.7)
Clinical Frailty Score, n (%)
    1. Very fit 4 (2.3) 8 (4.5) 12 (3.4)
    2. Well 20 (11.3) 15 (8.5) 35 (9.9)
    3. Managing well 34 (19.2) 48 (27.3) 82 (23.2)
    4. Vulnerable 43 (24.3) 51 (28.9) 94 (26.6)
    5. Mildly frail 36 (20.3) 31 (17.6) 67 (18.9)
    6. Moderately frail 35 (19.7) 19 (10.8) 54 (15.3)
    7. Severely frail 4 (2.3) 3 (2.3) 8 (2.3)
    9. Terminally ill 1 (0.6) 0 1 (0.3)
Nutritional status, n (%)
    Malnourished 16 (9.0) 11 (6.3) 27 (7.7)
    Risk of malnutrition 58 (32.8) 41 (23.3) 99 (28.1)
    Normal status 103 (58.2) 124 (70.5) 227 (64.3)

EQ-5D-5L, EuroQoL 5-dimension 5-level; IQR, interquartile range; ISAR, Identification of Seniors at Risk; MTS, Manchester Triage System; SD, Standard deviation.

Triage categories are presented as per MTS.

*“Other” residential status refers to living arrangements not fitting existing categories (e.g., living with others, not family members).

**“Other” source of referral refers to referrals other than those listed.

***Index complaints are presented here from most to least common, independent of MTS category.

“Other” complaints include abdominal pain; abscess and local infection; chest pain; collapsed adult; diarrhoea and vomiting; facial problems; gastrointestinal bleeds; head injury; headache; major trauma; shortness of breath; urinary problems; and wounds.

Patients’ outcomes related to their index visit are presented in Table 3. Participants in the intervention group spent almost 50% less time in the ED when compared to the control group (median hours 6.43 versus 12.10; Mann–Whitney Z = 4.82, p < 0.001) and had a significant reduced risk of hospital admissions (OR = 0.18, 95% CI 0.11 to 0.31, p < 0.001). To account for the potential influence of clinical severity, and considering potential baseline differences in triage category, age, and health status, we conducted sensitivity analyses controlling for triage category, age, ISAR score, nutritional status, and clinical frailty score, both for ED length of stay (using linear regression) and for rates of hospital admissions (logistic regression); these can be seen in S1 Sensitivity Analyses. For both measures, the differences between intervention and control group were statistically significant even when considering potential differences in clinical conditions. Participants in the intervention group reported higher satisfaction with the care received in the ED when compared to the control group (p = 0.008). There was no evidence of a difference between the 2 groups with regard to the length of stay in hospital for patients who were ultimately admitted (p = 0.32).

Table 3. Index visit outcomes.

Outcome Control (n = 177) Intervention (n = 176) Adjusted OR (95% CI) p-value Mean difference (95% CI) p-value Mann–Whitney test
ED length of stay (hours), median (IQR) 12.1 (6.18–22.14) 6.43 (4.05–14.87) Z = 4.82
p < 0.001
Hospital admissions, n (%) 99 (55.9) 34 (19.3) 0.18 (0.11, 0.31) p < 0.001
Hospital length of stay (days), median (IQR) (n = 133) 9 (5–24) 9 (3–13) Z = 0.99
p = 0.32
Patient satisfaction, mean ± SD (n = 318) 24.8 ± 3.74 25.8 ± 3.03 −1.01 (−1.76, −0.26) p = 0.008

CI, confidence interval; IQR, interquartile range; OR, odds ratio; SD, standard deviation.

At 30-day follow-up (Table 4), after adjusting for covariates, there was no evidence of a difference between the 2 groups in terms of unscheduled ED revisits (p = 0.23), unscheduled hospital admissions (p = 0.92), or nursing home admissions (p = 0.43). Participants in the intervention group reported higher functional status than those in the control group (p = 0.003). Sensitivity analyses of the delta of Barthel scores (30 days minus index visit) indicated that participants in the intervention group had a significant improvement from baseline to 30 days (mean = 0.21, SD = 2.91) compared to those in the control group (mean = −0.82, SD = 3.14); diff = −1.02, t(321) = −3.04, p = 0.003, Cohen’s d = 0.34. In terms of quality of life, patients in the intervention group reported better mobility (p = 0.02) and better self-care (p = 0.03) when controlling for age and ISAR score, but there was no evidence of significant differences in quality of life in terms of ability to perform usual activities (p = 0.22), discomfort (p = 0.97), or anxiety/depression (p = 0.47). Sensitivity analyses on the delta score for each of the EuroQoL subdimensions (30 days minus baseline) indicated no statistically significant differences between intervention and control group for any of the subdimensions.

Table 4. 30-day follow-up outcomes.

Outcome Control Intervention Adjusted estimate (95% CI)
ED revisits, n (%) (n = 353) 24 (13.6) 33 (18.8) OR = 1.42 (0.79, 2.55), p = 0.23
Unscheduled hospital admissions, n (%) (n = 353) 22 (12.4) 21 (11.9) OR = 0.96 (0.51, 1.84), p = 0.92
Nursing home admissions, n (%) (n = 353) 25 (14.1) 17 (9.7) OR = 0.76 (0.38, 1.51), p = 0.43
Barthel index, mean ± SD (n = 323) 15.56 ± 4.83 17.13 ± 3.52 b = 0.97 (0.32, 1.61), p = 0.003, R2 = 0.03
EQ-5D-5L, mean ± SD (n = 329)
    Mobility 2.27 ± 1.29 1.86 ± 1.11 b = −0.29 (−0.52, −0.06), p = 0.02, R2 = 0.03
    Self-care 2.34 ± 1.48 1.89 ± 1.23 b = −0.26 (−0.51, −0.02), p = 0.03, R2 = 0.03
    Usual activities 2.56 ± 1.36 2.22 ± 1.16 b = −0.14 (−0.37, 0.08), p = 0.22, R2 = 0.02
    Pain/discomfort 1.95 ± 1.08 2.02 ± 1.06 b = −0.01 (−0.22, 0.22), p = 0.97, R2 = 0.01
    Anxiety/depression 1.58 ± 0.92 1.46 ± 0.83 b = −0.06 (−0.25, 0.11), p = 0.47, R2 = 0.01

b, unstandardized coefficient adjusted for patient’s age, baseline ISAR score, baseline function (for Barthel), and baseline quality of life (for quality of life); CI, confidence interval; ED, emergency department; EQ-5D-5L, EuroQoL 5-dimension 5-level; ISAR, Identification of Seniors at Risk; OR, odds ratio adjusted for patient’s age and ISAR score at baseline; R2, coefficient of determination; SD, standard deviation.

A similar pattern of results was observed at 6 months (Table 5), although there was a significantly lower rate of unscheduled hospital admissions for patients in the intervention when compared to the control group (p = 0.02). Similar to 30-day follow-up, patients in the intervention group reported better function (p = 0.04). However, when we considered changes in Barthel scores between 30 days and 6 months, we noted that there were no significant differences between the 2 groups (intervention, mean = −0.03, SD = 2.32; control, mean = 0.08, SD = 2.58; t(282) = 0.39, p = 0.69). When considering quality of life, we found better self-care in the intervention group than in control group (p = 0.03) 6 months after their index visit, although the differences were small in size, but no differences in other measures of quality of life. When running sensitivity analyses on changes in quality of life between 30 days and 6 months, no significant differences were noted for any of the subdimensions.

Table 5. 6-month follow-up outcomes.

Outcome Control Intervention Adjusted estimate (95% CI)
ED revisits, n (%) (n = 346) 74 (43.3) 55 (31.4) OR = 0.65 (0.42, 1.02), p = 0.06
Unscheduled hospital admissions, n (%) (n = 346) 57 (33.3) 34 (19.4) OR = 0.53 (0.32, 0.88), p = 0.02
Nursing home admissions, n (%) (n = 304) 11 (7.5) 12 (7.6) OR = 1.16 (0.48, 2.78), p = 0.74
Barthel index, mean ± SD (n = 291) 16.32 ± 4.28 17.29 ± 3.52 b = 0.67 (0.02, 1.33), p = 0.04, R2 = 0.02
EQ-5D-5L*, mean ± SD (n = 297)
    Mobility 2.04 ± 1.31 1.73 ± 1.11 b = −0.21 (−0.45, 0.05), p = 0.11, R2 = 0.02
    Self-care 2.19 ± 1.43 1.72 ± 1.14 b = −0.33 (−0.58, −0.08), p = 0.009, R2 = 0.03
    Usual activities 2.29 ± 1.31 2.02 ± 1.16 b = −0.12 (−0.36, 0.12), p = 0.32, R2 = 0.01
    Pain/discomfort 1.73 ± 0.96 1.81 ± 0.99 b = −0.01 (−0.22, 0.21), p = 0.97, R2 = 0.001
    Anxiety/depression 1.44 ± 0.72 1.31 ± 0.65 b = −0.12 (−0.27, 0.04), p = 0.15, R2 = 0.01

b, unstandardized coefficient adjusted for patient’s age, baseline ISAR score, baseline function (for Barthel), and baseline quality of life (for quality of life); CI, confidence interval; ED, emergency department; EQ-5D-5L, EuroQoL 5-dimension 5-level; ISAR, Identification of Seniors at Risk; OR, odds ratio adjusted for patient’s age and ISAR score at baseline; R2, coefficient of determination; SD, standard deviation.

Discussion

Summary of findings

In this randomised controlled trial, early assessment and intervention by a dedicated HSCP team reduced the length of ED stay and incidence of hospital admission among older adults when compared to usual ED care. Patients in the intervention group reported higher satisfaction with the care received in the ED than in the control group, better function at 30-day and 6-month follow-up, better mobility (30 days), and better self-care (30 days and 6 months). No differences were observed at 30 days in terms of ED re-presentation, unscheduled hospital admission, or quality of life subdimensions of usual activities, discomfort, or anxiety. Considering objective outcomes at 6 months, patients in the intervention group had fewer unscheduled hospital admissions than those in the control group, but no significant differences were seen in terms of ED revisits or nursing home admissions.

Results in the context of existing evidence

This is, to the best of our knowledge, the first randomised controlled trial to evaluate the impact of a dedicated HSCP team on the care of older adults in the ED [16]. Evidence from existing studies supports the role of individual HSCPs in the ED in terms of reducing length of patient stay, avoiding unnecessary hospital admissions and improving the patient experience [16]. Furthermore, interdisciplinary care in the ED has been shown to enhance decision-making and contribute to timely and safe patient care, particularly for older adults [1012]. Participants in our study who were allocated to the intervention group experienced significantly shorter ED stays owing to the timely assessment, intervention, and decision-making by an interdisciplinary HSCP team. Our finding of reduced hospital admissions in the intervention group resonate with a previous nonrandomised study that reported a decrease in hospital admissions among older adults assessed by an ED-based HSCP team [16], although we observed a much larger difference between intervention and control group.

Our findings largely mirror those reported in a recent systematic review [31] that explored the impact of interventions aimed at improving clinical, patient experience, and healthcare utilisation for older adults presenting to the ED. Interventions across the 15 included studies (9 randomised controlled trials) were heterogeneous and comprised a variety of strategies (case management, discharge planning, and management/medication safety) delivered during the ED visit, following discharge and across the ED–primary care interface. While variation in the conduct and reporting of studies limited the strength of the conclusions drawn, when considering the interventions collectively, the authors reported a small benefit on functional status but no overall effect on ED return visit(s) or subsequent hospitalisation. Furthermore, interventions that bridged care occurring before and after ED discharge were associated with better outcomes. Our study did not include an intervention component that bridged the primary–secondary care interface and highlights the need to focus on interventions that integrate care before and after ED discharge.

Overall, we found that older adults across the intervention and control group reported high levels of satisfaction with care received in the ED, with those allocated to the intervention reporting significantly higher satisfaction with care than those in the control group. This finding aligns with those of previous studies [15,32,33], although the use of different assessment tools limits our ability to compare results. The follow-up differences observed in quality of life measures of mobility and self-care in contrast with those noted in Hughes and colleagues [31], although the studies included in their review used different measures of quality of life; this may point at the potential usefulness of assessing domain-specific aspects of quality of life.

Strengths and limitations

In line with the MRC framework for the development and evaluation of complex interventions [20], our study employed a controlled and robust design to test the effectiveness of a low intensity model of care (short duration and limited number of patient contacts) in the ED. Also, the design trial was informed by a systematic review [16], key ED stakeholders’ views [18], and a routine analysis of ED patient flow nationally to ensure the most optimal care pathways and inclusion criteria for the intervention. We assessed a comprehensive range of key outcomes to draw comparisons with existing literature and to provide conclusions on impact both at the patient and process level. Furthermore, our study was powered by an adequate sample size.

Our study is not without limitations. We focused on a specific cohort of “lower-urgency” patients with a range of index complaints that were amenable to HSCP intervention. This rationale was informed by our stakeholder input but, together with the fact that this is a single-centre trial, may limit the generalisability of the findings. We were unable to blind patients or ED staff members to allocation due to the nature of the intervention and the pragmatics of clinical practice in the ED, which may introduce a performance bias. Finally, our intervention was solely based in the ED and did not focus on care integration following discharge from the ED.

Implications for practice and research

Older adults are frequent attendees at the ED and experience high rates of adverse outcomes following ED presentation. It is imperative that future research examines innovative models of care to meet the complex needs of this heterogeneous population. The findings of this study advance our knowledge on the clinical effectiveness of HSCP teams caring for older adults with a variety of complaints in the ED and support the viability of this model of care as a strategy to reduce ED length of stay and the risk of unnecessary hospital admissions for older individuals, who are at the highest risk of adverse outcome following an ED visit [8]. On the other hand, the intervention did not reduce the incidence of ED re-presentations, suggesting the need for research to explore if integrated care packages involving community services to support older adults to live well in their own homes and communities are effective. Furthermore, a more in-depth exploration of the reasons for ED attendance among “lower-urgency” patients is warranted. It is possible that these patients may possess a lower threshold for attendance due to a myriad of factors including lower level of social and family support in the community and perceptions that the ED is reliable, accessible, and has the required expertise to deal with their presenting complaints [34,35].

Conclusions

Identifying optimal intervention strategies to enhance the care of older adults in the ED is urgently needed in light of increasing ED attendances and associated negative impact on patient and process outcomes. In this randomised controlled trial, we found that early assessment and intervention by a dedicated HSCP team led to shorter stays in the ED, reduced risk of hospital admissions, and higher patient satisfaction at index visit. Our study thus supports the effectiveness of this model of care for key ED and patient outcomes.

Supporting information

S1 CONSORT Checklist. Consolidated Standards of Reporting Trials (CONSORT) checklist for the study.

(DOC)

S1 Intervention Characteristics. Characteristics of assessment and intervention by the health and social care team.

(DOCX)

S1 Sensitivity Analyses. Sensitivity analyses on outcomes ED length of stay and hospital admissions.

(DOCX)

Abbreviations

ADLs

activities of daily living

ANCOVA

analysis of covariance

CI

confidence interval

CONSORT

Consolidated Standards of Reporting Trials

ED

emergency department

EM

emergency medicine

EQ-5D-5L

EuroQoL 5-dimension 5-level

GP

general practitioner

HSCP

health and social care professional

HSE

Health Service Executive

ISAR

Identification of Seniors at Risk

MNA

Mini Nutritional Assessment

MRC

Medical Research Council

MTS

Manchester Triage System score

OR

odds ratio

PET

Patient Experience Time

PSQ-18

18-item Patient Satisfaction Questionnaire

Data Availability

The data used in this study are available on the Open Science Framework at the public link https://osf.io/5wpjm/.

Funding Statement

This research is supported by the Health Research Board of Ireland through the Research Collaborative for Quality and Patient Safety (RCQPS) 2017, granted to the Principal Investigator (RG). The sponsor was not involved in the design of the study and collection, analysis, interpretation of data, or in writing the manuscript.

References

  • 1.Hoot NR, Aronsky D. Systematic Review of Emergency Department Crowding: Causes, Effects, and Solutions. Ann Emerg Med. 2008;52:126–136.e1. doi: 10.1016/j.annemergmed.2008.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Uscher-Pines L, Pines J, Kellermann A, Gillen E, Mehrotra A. Deciding to Visit the Emergency Departement for Non-Urgent Conditions: A Systematic Review of the Literature. Am J Manag Care. 2013;19:47–59. [PMC free article] [PubMed] [Google Scholar]
  • 3.van Tiel S, Rood PPM, Bertoli-Avella AM, Erasmus V, Haagsma J, van Beeck E, et al. Systematic review of frequent users of emergency departments in non-US hospitals. Eur J Emerg Med. 2015;22:306–15. doi: 10.1097/MEJ.0000000000000242 [DOI] [PubMed] [Google Scholar]
  • 4.Morley C, Unwin M, Peterson GM, Stankovich J, Kinsman L. Emergency department crowding: A systematic review of causes, consequences and solutions. PLoS ONE. 2018;13:e0203316. doi: 10.1371/journal.pone.0203316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Carter EJ, Pouch SM, Larson EL. The Relationship Between Emergency Department Crowding and Patient Outcomes: A Systematic Review. J Nurs Scholarsh. 2014;46:106–15. doi: 10.1111/jnu.12055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Oredsson S, Jonsson H, Rognes J, Lind L, Göransson KE, Ehrenberg A, et al. A systematic review of triage-related interventions to improve patient flow in emergency departments. Scand J Trauma Resusc Emerg Med. 2011;19:43. doi: 10.1186/1757-7241-19-43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shen Y. Association between the elderly frequent attender to the emergency department and 30-day mortality: A retrospective study over 10 years. World J Emerg Med. 2018;9:20. doi: 10.5847/wjem.j.1920-8642.2018.01.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schnitker L, Martin-Khan M, Beattie E, Gray L. Negative health outcomes and adverse events in older people attending emergency departments: A systematic review. Australas Emerg Nurs J. 2011;14:141–62. doi: 10.1016/j.aenj.2011.04.001 [DOI] [Google Scholar]
  • 9.Kilner E. What Evidence is There That a Physiotherapy Service in the Emergency Department Improves Health Outcomes? A Systematic Review. J Health Serv Res Policy. 2011;16:51–8. doi: 10.1258/jhsrp.2010.009129 [DOI] [PubMed] [Google Scholar]
  • 10.James K, Jones D, Kempenaar L, Preston J, Kerr S. Occupational therapy and emergency departments: A critical review of the literature. Br J Occup Ther. 2016;79:459–66. doi: 10.1177/0308022616629168 [DOI] [Google Scholar]
  • 11.Hickman LD, Phillips JL, Newton PJ, Halcomb EJ, Al Abed N, Davidson PM. Multidisciplinary team interventions to optimise health outcomes for older people in acute care settings: A systematic review. Arch Gerontol Geriatr. 2015;61:322–9. doi: 10.1016/j.archger.2015.06.021 [DOI] [PubMed] [Google Scholar]
  • 12.Allen J, Hutchinson AM, Brown R, Livingston PM. Quality care outcomes following transitional care interventions for older people from hospital to home: A systematic review. BMC Health Serv Res. 2014;14:346. doi: 10.1186/1472-6963-14-346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Innes K, Crawford K, Jones T, Blight R, Trenham C, Williams A, et al. Transdisciplinary care in the emergency department: A qualitative analysis. Int Emerg Nurs. 2016;25:27–31. doi: 10.1016/j.ienj.2015.07.003 [DOI] [PubMed] [Google Scholar]
  • 14.Nielsen L, Maribo T, Kirkegaard H, Petersen KS, Lisby M, Oestergaard LG. Effectiveness of the “Elderly Activity Performance Intervention” on elderly patients’ discharge from a short-stay unit at the emergency department: a quasi-experimental trial. Clin Interv Aging. 2018;13:737–47. doi: 10.2147/CIA.S162623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Taylor NF, Norman E, Roddy L, Tang C, Pagram A, Hearn K. Primary contact physiotherapy in emergency departments can reduce length of stay for patients with peripheral musculoskeletal injuries compared with secondary contact physiotherapy: A prospective non-randomised controlled trial. Physiotherapy. 2011;97:107–14. doi: 10.1016/j.physio.2010.08.011 [DOI] [PubMed] [Google Scholar]
  • 16.Cassarino M, Robinson K, Quinn R, Naddy B, O’Regan A, Ryan D, et al. Impact of early assessment and intervention by teams involving health and social care professionals in the emergency department: A systematic review. PLoS ONE. 2019;14:e0220709. doi: 10.1371/journal.pone.0220709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ferreira GE, Traeger AC. O’keeffe M, Maher CG. Staff and patients have mostly positive perceptions of physiotherapists working in emergency departments: a systematic review. J Physiother. 2018;64:229–36. doi: 10.1016/j.jphys.2018.08.001 [DOI] [PubMed] [Google Scholar]
  • 18.Cassarino M, Quinn R, Boland F, Ward ME, McNamara R, O’Connor M, et al. Stakeholders’ perspectives on models of care in the emergency department and the introduction of health and social care professional teams: A qualitative analysis using World Cafés and interviews. Health Expect. 2020; hex.13033. doi: 10.1111/hex.13033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wylie K, Crilly J, Toloo GS, FitzGerald G, Burke J, Williams G, et al. Review article: Emergency department models of care in the context of care quality and cost: A systematic review. Emerg Med Australas. 2015;27:95–101. doi: 10.1111/1742-6723.12367 [DOI] [PubMed] [Google Scholar]
  • 20.Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cassarino M, Robinson K, O’Shaughnessy Í, Smalle E, White S, Devlin C, et al. A randomised controlled trial exploring the impact of a dedicated health and social care professionals team in the emergency department on the quality, safety, clinical and cost-effectiveness of care for older adults: A study protocol. Trials. 2019;20:591. doi: 10.1186/s13063-019-3697-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cassarino M, Cronin Ú, Robinson K, Quinn R, Boland F, Ward ME, et al. Implementing an allied health team intervention to improve the care of older adults in the emergency department: protocol for a process evaluation. BMJ Open. 2019;9:e032645. doi: 10.1136/bmjopen-2019-032645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:698–702. doi: 10.1136/bmj.c332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Parenti N, Reggiani MLB, Iannone P, Percudani D. Dowding D. A systematic review on the validity and reliability of an emergency department triage scale, the Manchester Triage System. Int J Nurs Stud. 2014;51:1062–9. doi: 10.1016/j.ijnurstu.2014.01.013 [DOI] [PubMed] [Google Scholar]
  • 25.Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Md State Med J. 1965;14:61–5. [PubMed] [Google Scholar]
  • 26.Rabin R. Charro F de. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43. doi: 10.3109/07853890109002087 [DOI] [PubMed] [Google Scholar]
  • 27.Galvin R, Gilleit Y, Wallace E, Cousins G, Bolmer M, Rainer T, et al. Adverse outcomes in older adults attending emergency departments: a systematic review and meta-analysis of the Identification of Seniors At Risk (ISAR) screening tool. Age Ageing. 2016;35:1–8. doi: 10.1093/ageing/afw233 [DOI] [PubMed] [Google Scholar]
  • 28.Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173:489–95. doi: 10.1503/cmaj.050051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rubenstein LZ, Harker JO, Salvà A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001;56:M366–72. doi: 10.1093/gerona/56.6.m366 [DOI] [PubMed] [Google Scholar]
  • 30.Marshall GN, Hays RD. The Patient Satisfaction Questionnaire Short Form (PSQ-18) . Santa Monica, CA: Rand; 1994. Available from: https://www.rand.org/content/dam/rand/pubs/papers/2006/P7865.pdf [Google Scholar]
  • 31.Hughes JM, Freiermuth CE, Shepherd-Banigan M, Ragsdale L, Eucker SA, Goldstein K, et al. Emergency Department Interventions for Older Adults: A Systematic Review. J Am Geriatr Soc. 2019;67:1516–25. doi: 10.1111/jgs.15854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Moss JE, Houghton LM, Flower CL, Moss DL, Nielsen DA, Taylor DM. A multidisciplinary Care Coordination Team improves emergency department discharge planning practice. Med J Aust. 2002;177:427–39. doi: 10.5694/j.1326-5377.2002.tb04884.x [DOI] [PubMed] [Google Scholar]
  • 33.Corbett HM, Lim WK, Davis SJ, Elkins AM. Care coordination in the Emergency Department: improving outcomes for older patients. Aust Health Rev. 2005;29:43–50. doi: 10.1071/ah050043 [DOI] [PubMed] [Google Scholar]
  • 34.Agarwal S, Banerjee J, Baker R, Conroy S, Hsu R, Rashid A, et al. Potentially avoidable emergency department attendance: Interview study of patients’ reasons for attendance. Emerg Med J. 2012. doi: 10.1136/emermed-2011-200585 [DOI] [PubMed] [Google Scholar]
  • 35.Hunter C, Chew-Graham C, Langer S, Stenhoff A, Drinkwater J, Guthrie E, et al. A qualitative study of patient choices in using emergency health care for long-term conditions: The importance of candidacy and recursivity. Patient Educ Couns. 2013. doi: 10.1016/j.pec.2013.06.001 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Richard Turner

4 Nov 2020

Dear Dr Cassarino,

Thank you for submitting your manuscript entitled "Randomised controlled trial of the impact of a Health and Social Care Professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults." for consideration by PLOS Medicine.

Your manuscript has now been evaluated by the PLOS Medicine editorial staff and I am writing to let you know that we would like to send your submission out for external assessment.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by .

Login to Editorial Manager here: https://www.editorialmanager.com/pmedicine

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Feel free to email us at plosmedicine@plos.org if you have any queries relating to your submission.

Kind regards,

Richard Turner, PhD

Senior editor, PLOS Medicine

rturner@plos.org

Decision Letter 1

Richard Turner

19 Dec 2020

Dear Dr. Cassarino,

Thank you very much for submitting your manuscript "Randomised controlled trial of the impact of a Health and Social Care Professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults." (PMEDICINE-D-20-05367R1) for consideration at PLOS Medicine.

Your paper was evaluated by the editors and sent to independent reviewers, including a statistical reviewer. The reviews are appended at the bottom of this email and any accompanying reviewer attachments can be seen via the link below:

[LINK]

In light of these reviews, we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to invite you to submit a revised version that addresses the reviewers' and editors' comments fully. You will appreciate that we cannot make a decision about publication until we have seen the revised manuscript and your response, and we expect to seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments, the changes you have made in the manuscript, and include either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

We hope to receive your revised manuscript by Jan 11 2021 11:59PM. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

Please use the following link to submit the revised manuscript:

https://www.editorialmanager.com/pmedicine/

Your article can be found in the "Submissions Needing Revision" folder.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosmedicine/s/submission-guidelines#loc-methods.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

Please let me know if you have any questions. Otherwise, we look forward to receiving your revised manuscript in due course.

Sincerely,

Richard Turner, PhD

Senior Editor, PLOS Medicine

rturner@plos.org

-----------------------------------------------------------

Requests from the editors:

Please ensure that the data statement complies with PLOS' data policy (https://journals.plos.org/plosmedicine/s/data-availability), noting that study authors cannot be listed as points of contact for readers interested in inquiring about access to study data.

Please adapt the title so that the study descriptor appears after a colon (i.e., "...: a randomized controlled trial").

Please restructure your abstract into a three-part structure preferred at PLOS Medicine. The final sentence of the "Methods and Findings" subsection should begin "Study limitations include ..." or similar and quote 2-3 of the study's main limitations.

Please quote summary demographic characteristics for study participants in the abstract.

After the abstract, we will need to ask you to add a new and accessible "author summary" section in non-identical prose. You may find it helpful to consult one or two recent research papers in PLOS Medicine to get a sense of the preferred style.

Please indicate in the methods section if consent was "informed".

Please substitute "sex" for "gender" where appropriate.

Throughout the text, please format reference call-outs as follows: "... poorer health outcomes [4,5].".

Please remove the information on funding, competing interests and data sharing from the end of the main text. In the event of publication, this information will appear in the article metadata via entries in the submission form.

Please ensure that all reference citations contain full access information (e.g., reference 4).

Please correct the typo in reference 20.

Please add the full author names to reference 33.

Please remove all publisher names (e.g., "Elsevier") and iterations of "[Internet]" from the reference list.

Please adapt the attached CONSORT checklist so that individual items are referred to by section (e.g., "Methods") and paragraph number rather than by page or line numbers, as the latter generally change in the event of publication. Please refer to this in the text as "See S1_CONSORT_Checklist" or similar, and amend the attachment label to match.

Comments from the reviewers:

*** Reviewer #1:

This manuscript is well-written and easy to follow. I just have a few, relatively minor, comments listed below:

Looking at Table 2, patients randomised to the Control group appear to me as if being slightly less healthy that those randomised to the intervention group. For example, 43% vs 31% were identified as mildly frail or worse in the control and intervention groups respectively. I also note some differences in ISAR score and nutritional status. I would like the authors to consider describing these differences in the text as well as consider running sensitivity analyses that adjust for these baseline imbalances. I realise that a non-parametric test was used to assess differences in the primary outcome (length of ED stay); however, as a sensitivity analysis one could consider using a linear model which allows covariates.

Is it possible for the authors to add a table describing the intervention as delivered such as the types of activities performed and/or the time spent with the patient?

Please add the fact that the study was conducted in a single centre as one of the limitations (lack of generalisability).

Assuming that the same HSCP staff interacted with patient randomised to both arms, I would like to understand whether contamination (i.e. HSCP staff doing more under usual care than they would normally) occurred and what was put in place to prevent it.

A number of patients were excluded from the analysis of ED and hospital admissions at 30 days and 6 months due to death or lost-to-FU. Instead of excluding these patients, one could consider an alternative approach that take exposure/censoring into account. Possible methods include calculating rates (e.g. rates of admission) while adjusting for exposure or using a time-to-event analysis censored for death or loss-to-FU. One would need to consider how to handle death e.g. as a competing risk. I would encourage the authors to consider some of these options as a sensitivity analysis.

Please consider adding the pre-specified analysis plan in the appendix.

-Laurent Billot

*** Reviewer #2:

please, find the enclosed file

*** Reviewer #3:

General comments:

This is an interesting, important and timely study on improving post-ED outcomes for older adults seen in the ED utilizing a multidisciplinary HSCP team comprised of a social worker, occupational therapist and physiotherapist. The impressive reductions in ED length of stay and hospital admission rates, as well as improvements in 30-day function, mobility and self care generate enthusiasm for this potentially relatively uncomplicated intervention. However, one important aspect that limits the ability to apply and generalize the results to other settings is some description of what exactly the scope of the HSCP team was on patient care. Was it an assessment only with communication of findings to the medical team for them to determine treatment and follow-up care, an in-ED treatment intervention, an intervention including self-practice skills for home, a transition of care to an outpatient provider, or something else? The discussion suggests that transition of care did not occur, but more explicit description in the main methods and results would be important. If it was a combination, what percentage of cases fell into the various categories or multiple categories? How was a tailored approach determined if used? How long did the assessment and intervention take, and how many patients was the team actually able to intervene on in a day? Understanding the level of expertise and resources required will help inform how practical or translatable the content of the intervention is to other EDs.

Additional specific comments below for clarification of some of the sections:

Abstract:

Participants: It would be helpful to include a couple words describing the inclusion criteria and/or whether this was a convenience sample, to give the reader a better sense from the abstract who the intervention was applied to. E.g. patients presenting between certain hours, and/or the overarching theme of the index complaints (e.g. illness or injury causing impairment of baseline functional status).

Introduction:

Page 6: The second sentence could be re-worded for clarity and grammar (e.g. incremental *increases* in ED attendance)

Page 7: First sentence of the second paragraph has multiple typographical and wording errors that make it confusing as to what the target outcome measures are. Please clarify to make it clear what the target outcomes are.

Page 8: Participants and recruitment: As in the abstract, it would be helpful to give a brief description of the theme of the inclusion criteria to better understand the target population (e.g. older adults whose illness or injury cause impairment of baseline functional status).

For the very urgent cases, would be helpful to specify what criteria were used after the work-up to deem them able to be invited (e.g. life-threatening causes ruled out, or likely to be discharged).

Page 10: Baseline data collection: For falls and hospitalizations, do you mean incidence (which is a proportion and usual population-based), or *number* of times for the individual? This seems like it should be "number"; if so, please re-word.

Page 11: Unclear what is meant by the term "bleeped". Please rephrase for clarity.

***

Any attachments provided with reviews can be seen via the following link:

[LINK]

Attachment

Submitted filename: revisione plos medicine16_12[16876].docx

Decision Letter 2

Richard Turner

8 May 2021

Dear Dr. Cassarino,

Thank you very much for submitting your revised manuscript "Impact of a Health and Social Care Professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults: a randomised controlled trial" (PMEDICINE-D-20-05367R2) for consideration at PLOS Medicine.

Your paper was discussed among the editors and sent to the reviewers, including our statistical reviewer. The reviews are appended at the bottom of this email and any accompanying reviewer attachments can be seen via the link below:

[LINK]

In light of these reviews, we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to ask you to submit a further revised version that fully addresses the reviewers' and editors' comments. You will recognize that we cannot make a decision about publication until we have seen the revised manuscript and your response, and we plan to seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments, the changes you have made in the manuscript, and include either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

We hope to receive your revised manuscript by May 31 2021 11:59PM. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

Please use the following link to submit the revised manuscript:

https://www.editorialmanager.com/pmedicine/

Your article can be found in the "Submissions Needing Revision" folder.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

Please let me know if you have any questions, and we look forward to receiving your revised manuscript.

Sincerely,

Richard Turner, PhD

Senior Editor, PLOS Medicine

rturner@plos.org

-----------------------------------------------------------

Requests from the editors:

Please make that "data ... are" in your data statement (submission form).

You may wish to note the element of assessment (by the team) in your title.

Please substitute a colon for the semicolon in your title.

In the Methods section, please refer to figure 1 as "Participant flowchart" or similar rather than "CONSORT flowchart".

Please remove the information on ethics approval from the end of the main text (this belongs in the Methods section) and the information on transparency and dissemination.

Please use the abbreviation "PLoS ONE" in your reference list.

Comments from the reviewers:

*** Reviewer #1:

Most of my comments have been adequately addressed; however, I have one remaining issue which relates to the adjustment for baseline imbalances.

The authors state that it was not necessary to adjust for differences in ISAR score, frailty or nutrition status given that tests comparing the two arms at baseline were not significant.

I believe that using significance tests to decide whether or not to adjust for baseline differences is potentially misleading due to the following reasons:

1) p-values measure the degree of consistency between the null hypothesis and the observed data. In the case of a randomised trial, we know that the null hypothesis is in fact true (i.e. that there is no true difference between the two randomised arms) and that any observed difference is due to chance.

2) One may not have the appropriate power to test for baseline differences

For these reasons, I believe it is important to decide whether or not to adjust, not based on tests of significance, but on observed differences. To quantify the differences, one option is to use standardised differences which do not depend on the sample size.

I would therefore strongly suggest adding the ISAR score, the frailty status and the nutrition status to the adjusted model already containing the triage category.

-Laurent Billot

*** Reviewer #2:

Thank you for submitting the revised version of the manuscript.

I thank the authors for taking into account all comments. The answers given are satisfactory. In particular, I appreciate the sensitivity analyses added, which reinforce the results. The description of the intervention characteristics is clear and detailed.

I have no more comments.

*** Reviewer #3:

The revised manuscript is much clearer and addresses previous concerns.

***

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 3

Richard Turner

22 Jun 2021

Dear Dr. Cassarino,

Thank you very much for re-submitting your manuscript "Impact of assessment and intervention by a Health and Social Care Professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults: a randomised controlled trial." (PMEDICINE-D-20-05367R3) for consideration at PLOS Medicine.

I have discussed the paper with editorial colleagues and it was also seen again by one reviewer. I am pleased to tell you that, once the remaining editorial and production issues are fully dealt with, we expect to be able to accept the paper for publication in the journal.

The remaining issues that need to be addressed are listed at the end of this email. Any accompanying reviewer attachments can be seen via the link below. Please take these into account before resubmitting your manuscript:

[LINK]

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

In revising the manuscript for further consideration here, please ensure you address the specific points made by each reviewer and the editors. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file. A version with changes marked must also be uploaded as a marked up manuscript file.

Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. If you haven't already, we ask that you provide a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract.

We hope to receive your revised manuscript within 1 week. Please email us (plosmedicine@plos.org) if you have any questions or concerns.

We ask every co-author listed on the manuscript to fill in a contributing author statement. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

Please note, when your manuscript is accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosmedicine@plos.org.

Please let me know if you have any questions, and we look forward to receiving the revised manuscript.   

Sincerely,

Richard Turner, PhD

Senior Editor, PLOS Medicine

rturner@plos.org

------------------------------------------------------------

Requests from Editors:

Please quote aggregate demographic details for study participants in the abstract, i.e., age and sex from the rightmost column of table 2.

Where appropriate, e.g., in the abstract, please substitute "sex" for "gender".

In the author summary, please use the active voice (e.g., "We aimed ...) in at least one point.

Comments from Reviewers:

*** Reviewer #1:

The auhors have adequately addressed my last comment. I have no further comment.

-Laurent Billot

***

Any attachments provided with reviews can be seen via the following link:

[LINK]

Decision Letter 4

Richard Turner

26 Jun 2021

Dear Dr Cassarino, 

On behalf of my colleagues, I am pleased to inform you that we have agreed to publish your manuscript "Impact of assessment and intervention by a Health and Social Care Professional team in the emergency department on the quality, safety, and clinical effectiveness of care for older adults: a randomised controlled trial." (PMEDICINE-D-20-05367R4) in PLOS Medicine.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Once you have received these formatting requests, please note that your manuscript will not be scheduled for publication until you have made the required changes.

Prior to final acceptance, please add a few words to your abstract to quote the study dates.

In the meantime, please log into Editorial Manager at http://www.editorialmanager.com/pmedicine/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. 

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with medicinepress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for submitting to PLOS Medicine. We look forward to publishing your paper. 

Sincerely, 

Richard Turner, PhD 

Senior Editor, PLOS Medicine

rturner@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 CONSORT Checklist. Consolidated Standards of Reporting Trials (CONSORT) checklist for the study.

    (DOC)

    S1 Intervention Characteristics. Characteristics of assessment and intervention by the health and social care team.

    (DOCX)

    S1 Sensitivity Analyses. Sensitivity analyses on outcomes ED length of stay and hospital admissions.

    (DOCX)

    Attachment

    Submitted filename: revisione plos medicine16_12[16876].docx

    Attachment

    Submitted filename: PMEDICINE-D-20-05367R1_ResponseToReviewers.docx

    Attachment

    Submitted filename: PMEDICINE-D-20-05367R2_ResponseToReviewers.docx

    Attachment

    Submitted filename: PMEDICINE-D-20-05367R3_ResponseToReviewer.docx

    Data Availability Statement

    The data used in this study are available on the Open Science Framework at the public link https://osf.io/5wpjm/.


    Articles from PLoS Medicine are provided here courtesy of PLOS

    RESOURCES